Osborn Group, Inc.

Osborn Group, Inc. — FDA 510(k) Submissions

Osborn Group, Inc. has submitted 4 FDA 510(k) premarket notifications since 1999, of which 4 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Assay, Glycosylated Hemoglobin, Turbidimetric Method, Protein Or Albumin (urinary, Non-quant.), Tubes, Vials, Systems, Serum Separators, Blood Collection, Alkaline Picrate, Colorimetry, Creatinine . Use the specialty filter in the sidebar to narrow results.